Literature DB >> 26564392

A Simple Mouse Model for the Study of Human Immunodeficiency Virus.

Kang Chang Kim1, Byeong-Sun Choi2, Kyung-Chang Kim2, Ki Hoon Park1, Hee Jung Lee1, Young Keol Cho3, Sang Il Kim4, Sung Soon Kim2, Yu-Kyoung Oh5, Young Bong Kim1.   

Abstract

Humanized mouse models derived from immune-deficient mice have been the primary tool for studies of human infectious viruses, such as human immunodeficiency virus (HIV). However, the current protocol for constructing humanized mice requires elaborate procedures and complicated techniques, limiting the supply of such mice for viral studies. Here, we report a convenient method for constructing a simple HIV-1 mouse model. Without prior irradiation, NOD/SCID/IL2Rγ-null (NSG) mice were intraperitoneally injected with 1 × 10(7) adult human peripheral blood mononuclear cells (hu-PBMCs). Four weeks after PBMC inoculation, human CD45(+) cells, and CD3(+)CD4(+) and CD3(+)CD8(+) T cells were detected in peripheral blood, lymph nodes, spleen, and liver, whereas human CD19(+) cells were observed in lymph nodes and spleen. To examine the usefulness of hu-PBMC-inoculated NSG (hu-PBMC-NSG) mice as an HIV-1 infection model, we intravenously injected these mice with dual-tropic HIV-1DH12 and X4-tropic HIV-1NL4-3 strains. HIV-1-infected hu-PBMC-NSG mice showed significantly lower human CD4(+) T cell counts and high HIV viral loads in the peripheral blood compared with noninfected hu-PBMC-NSG mice. Following highly active antiretroviral therapy (HAART) and neutralizing antibody treatment, HIV-1 replication was significantly suppressed in HIV-1-infected hu-PBMC-NSG mice without detectable viremia or CD4(+) T cell depletion. Moreover, the numbers of human T cells were maintained in hu-PBMC-NSG mice for at least 10 weeks. Taken together, our results suggest that hu-PBMC-NSG mice may serve as a relevant HIV-1 infection and pathogenesis model that could facilitate in vivo studies of HIV-1 infection and candidate HIV-1 protective drugs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26564392      PMCID: PMC4761813          DOI: 10.1089/AID.2015.0211

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  48 in total

1.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.

Authors:  C C Bleul; L Wu; J A Hoxie; T A Springer; C R Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

2.  Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.

Authors:  I Ourmanov; M Bilska; V M Hirsch; D C Montefiori
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.

Authors:  I Ourmanov; C R Brown; B Moss; M Carroll; L Wyatt; L Pletneva; S Goldstein; D Venzon; V M Hirsch
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function.

Authors:  O Kollet; A Peled; T Byk; H Ben-Hur; D Greiner; L Shultz; T Lapidot
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

5.  Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

Authors:  J D Boyer; K E Ugen; B Wang; M Agadjanyan; L Gilbert; M L Bagarazzi; M Chattergoon; P Frost; A Javadian; W V Williams; Y Refaeli; R B Ciccarelli; D McCallus; L Coney; D B Weiner
Journal:  Nat Med       Date:  1997-05       Impact factor: 53.440

6.  Potent activity of 2'-beta-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice.

Authors:  K Ruxrungtham; E Boone; H Ford; J S Driscoll; R T Davey; H C Lane
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

7.  The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.

Authors:  G R Picchio; R J Gulizia; K Wehrly; B Chesebro; D E Mosier
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice.

Authors:  R J Gulizia; R G Collman; J A Levy; D Trono; D E Mosier
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate.

Authors:  A J Conley; J A Kessler; L J Boots; P M McKenna; W A Schleif; E A Emini; G E Mark; H Katinger; E K Cobb; S M Lunceford; S R Rouse; K K Murthy
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice.

Authors:  Mineki Saito; Reiko Tanaka; Hideki Fujii; Akira Kodama; Yoshiaki Takahashi; Toshio Matsuzaki; Hiroshi Takashima; Yuetsu Tanaka
Journal:  Retrovirology       Date:  2014-08-28       Impact factor: 4.602

View more
  18 in total

Review 1.  Humanized mice: models for evaluating NeuroHIV and cure strategies.

Authors:  Jenna B Honeycutt; J Victor Garcia
Journal:  J Neurovirol       Date:  2017-08-22       Impact factor: 2.643

2.  Antibody-mediated prevention of vaginal HIV transmission is dictated by IgG subclass in humanized mice.

Authors:  Jacqueline M Brady; Meredith Phelps; Scott W MacDonald; Evan C Lam; Adam Nitido; Dylan Parsons; Christine L Boutros; Cailin E Deal; Wilfredo F Garcia-Beltran; Serah Tanno; Harini Natarajan; Margaret E Ackerman; Vladimir D Vrbanac; Alejandro B Balazs
Journal:  Sci Transl Med       Date:  2022-07-27       Impact factor: 19.319

Review 3.  HIV Latency in Myeloid Cells: Challenges for a Cure.

Authors:  Alisha Chitrakar; Marta Sanz; Sanjay B Maggirwar; Natalia Soriano-Sarabia
Journal:  Pathogens       Date:  2022-05-24

Review 4.  The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents.

Authors:  Y Maurice Morillon; Ariana Sabzevari; Jeffrey Schlom; John W Greiner
Journal:  Anticancer Res       Date:  2020-10       Impact factor: 2.480

5.  A New Humanized Mouse Model Mimics Humans in Lacking α-Gal Epitopes and Secreting Anti-Gal Antibodies.

Authors:  Fayez M Saleh; Partha K Chandra; Dong Lin; James E Robinson; Reza Izadpanah; Debasis Mondal; Christian Bollensdorff; Eckhard U Alt; Quan Zhu; Wayne A Marasco; Stephen E Braun; Ussama M Abdel-Motal
Journal:  J Immunol       Date:  2020-03-06       Impact factor: 5.422

6.  High activation and skewed T cell differentiation are associated with low IL-17A levels in a hu-PBL-NSG-SGM3 mouse model of HIV infection.

Authors:  F Perdomo-Celis; S Medina-Moreno; H Davis; J Bryant; N A Taborda; M T Rugeles; S Kottilil; J C Zapata
Journal:  Clin Exp Immunol       Date:  2020-01-21       Impact factor: 4.330

7.  The Establishment of an In Vivo HIV-1 Infection Model in Humanized B-NSG Mice.

Authors:  Tian-Jiao Fan; Li Sun; Xian-Guang Yang; Xia Jin; Wei-Wei Sun; Jian-Hua Wang
Journal:  Virol Sin       Date:  2019-12-21       Impact factor: 4.327

8.  μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies.

Authors:  Hannah S Sperber; Padma Priya Togarrati; Kyle A Raymond; Mohamed S Bouzidi; Renata Gilfanova; Alan G Gutierrez; Marcus O Muench; Satish K Pillai
Journal:  FASEB J       Date:  2020-09-09       Impact factor: 5.191

9.  Longitudinal imaging of HIV-1 spread in humanized mice with parallel 3D immunofluorescence and electron tomography.

Authors:  Collin Kieffer; Mark S Ladinsky; Allen Ninh; Rachel P Galimidi; Pamela J Bjorkman
Journal:  Elife       Date:  2017-02-15       Impact factor: 8.140

Review 10.  Human Immune System Mice for the Study of Human Immunodeficiency Virus-Type 1 Infection of the Central Nervous System.

Authors:  Teresa H Evering; Moriya Tsuji
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.